| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 419 | 2021 | 6853 | 19.830 |
Why?
|
| Prostatic Neoplasms | 304 | 2021 | 11345 | 11.150 |
Why?
|
| Vitamin D | 150 | 2021 | 3291 | 10.680 |
Why?
|
| Diet | 225 | 2021 | 8010 | 9.230 |
Why?
|
| Adenoma | 102 | 2021 | 2148 | 9.170 |
Why?
|
| Dietary Supplements | 76 | 2021 | 3392 | 5.490 |
Why?
|
| Anticarcinogenic Agents | 27 | 2018 | 249 | 4.960 |
Why?
|
| Prospective Studies | 632 | 2021 | 54303 | 4.860 |
Why?
|
| Colonic Neoplasms | 78 | 2020 | 2526 | 4.770 |
Why?
|
| Risk Factors | 709 | 2022 | 74359 | 4.740 |
Why?
|
| Alcohol Drinking | 87 | 2021 | 4013 | 4.700 |
Why?
|
| Coffee | 33 | 2020 | 582 | 4.570 |
Why?
|
| Body Mass Index | 165 | 2022 | 12914 | 4.510 |
Why?
|
| Carotenoids | 41 | 2018 | 620 | 4.320 |
Why?
|
| Obesity | 98 | 2022 | 12922 | 4.280 |
Why?
|
| C-Peptide | 27 | 2021 | 433 | 4.250 |
Why?
|
| Feeding Behavior | 83 | 2021 | 3185 | 4.030 |
Why?
|
| Hyperinsulinism | 18 | 2021 | 402 | 4.010 |
Why?
|
| Adiposity | 25 | 2022 | 1858 | 3.950 |
Why?
|
| Health Personnel | 79 | 2021 | 3310 | 3.870 |
Why?
|
| Neoplasms | 114 | 2021 | 22072 | 3.840 |
Why?
|
| Calcium, Dietary | 32 | 2021 | 531 | 3.820 |
Why?
|
| Middle Aged | 978 | 2021 | 220352 | 3.770 |
Why?
|
| Gallstones | 20 | 2021 | 283 | 3.730 |
Why?
|
| Folic Acid | 60 | 2021 | 1309 | 3.690 |
Why?
|
| Vitamin D Deficiency | 47 | 2021 | 1379 | 3.660 |
Why?
|
| Insulin-Like Growth Factor I | 41 | 2019 | 1928 | 3.630 |
Why?
|
| Incidence | 266 | 2021 | 21392 | 3.600 |
Why?
|
| Exercise | 70 | 2021 | 5787 | 3.590 |
Why?
|
| Follow-Up Studies | 337 | 2021 | 39261 | 3.470 |
Why?
|
| Aged | 797 | 2021 | 169152 | 3.380 |
Why?
|
| Vitamins | 38 | 2021 | 1634 | 3.300 |
Why?
|
| Proportional Hazards Models | 200 | 2021 | 12531 | 3.270 |
Why?
|
| Colonic Polyps | 22 | 2021 | 551 | 3.220 |
Why?
|
| Male | 1004 | 2022 | 359744 | 3.200 |
Why?
|
| Aspirin | 47 | 2021 | 3364 | 3.020 |
Why?
|
| Humans | 1397 | 2022 | 760621 | 2.980 |
Why?
|
| Adult | 747 | 2022 | 219994 | 2.960 |
Why?
|
| Risk | 145 | 2020 | 9631 | 2.950 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 31 | 2019 | 415 | 2.920 |
Why?
|
| Meat | 32 | 2020 | 584 | 2.820 |
Why?
|
| Smoking | 110 | 2021 | 9073 | 2.810 |
Why?
|
| Cohort Studies | 328 | 2021 | 41335 | 2.710 |
Why?
|
| Life Style | 65 | 2021 | 3896 | 2.710 |
Why?
|
| Case-Control Studies | 247 | 2021 | 22053 | 2.580 |
Why?
|
| Pancreatic Neoplasms | 78 | 2021 | 5351 | 2.560 |
Why?
|
| Dietary Fiber | 41 | 2021 | 760 | 2.470 |
Why?
|
| United States | 361 | 2021 | 72461 | 2.440 |
Why?
|
| Nuts | 14 | 2021 | 263 | 2.430 |
Why?
|
| Genetic Predisposition to Disease | 123 | 2021 | 17790 | 2.310 |
Why?
|
| Fruit | 34 | 2021 | 1160 | 2.270 |
Why?
|
| Female | 773 | 2022 | 391270 | 2.250 |
Why?
|
| Nurses | 63 | 2021 | 2467 | 2.230 |
Why?
|
| Insulin | 34 | 2020 | 6597 | 2.210 |
Why?
|
| Caffeine | 23 | 2020 | 702 | 2.180 |
Why?
|
| Polymorphism, Single Nucleotide | 133 | 2022 | 15789 | 2.120 |
Why?
|
| Body Composition | 7 | 2021 | 2419 | 2.110 |
Why?
|
| Prostate-Specific Antigen | 39 | 2020 | 2529 | 2.090 |
Why?
|
| Weight Gain | 16 | 2021 | 2347 | 2.060 |
Why?
|
| Ejaculation | 6 | 2018 | 59 | 2.050 |
Why?
|
| Cholecystectomy | 16 | 2021 | 406 | 2.050 |
Why?
|
| Dairy Products | 23 | 2021 | 494 | 1.990 |
Why?
|
| Vegetables | 39 | 2021 | 1196 | 1.970 |
Why?
|
| Risk Assessment | 164 | 2021 | 24123 | 1.940 |
Why?
|
| Vitamin B 6 | 17 | 2018 | 233 | 1.940 |
Why?
|
| Odds Ratio | 131 | 2021 | 9716 | 1.880 |
Why?
|
| Inflammation | 36 | 2021 | 10756 | 1.880 |
Why?
|
| Nutritional Physiological Phenomena | 8 | 2019 | 363 | 1.880 |
Why?
|
| Mortality | 17 | 2021 | 2916 | 1.870 |
Why?
|
| Gonadal Steroid Hormones | 18 | 2021 | 701 | 1.800 |
Why?
|
| Calcium | 23 | 2019 | 5725 | 1.790 |
Why?
|
| Motor Activity | 25 | 2015 | 2687 | 1.790 |
Why?
|
| Dietary Fats | 32 | 2020 | 1992 | 1.740 |
Why?
|
| Precancerous Conditions | 13 | 2021 | 977 | 1.710 |
Why?
|
| Vasectomy | 9 | 2020 | 51 | 1.690 |
Why?
|
| Cardiovascular Diseases | 48 | 2021 | 15757 | 1.650 |
Why?
|
| Glucosamine | 4 | 2020 | 128 | 1.580 |
Why?
|
| Prostatic Hyperplasia | 21 | 2020 | 530 | 1.580 |
Why?
|
| Microsatellite Instability | 35 | 2020 | 715 | 1.570 |
Why?
|
| Multivariate Analysis | 123 | 2020 | 12159 | 1.540 |
Why?
|
| Diet Surveys | 40 | 2021 | 1161 | 1.540 |
Why?
|
| Carcinoma | 20 | 2019 | 2331 | 1.510 |
Why?
|
| Cholecalciferol | 10 | 2020 | 550 | 1.480 |
Why?
|
| C-Reactive Protein | 23 | 2021 | 3839 | 1.480 |
Why?
|
| Urinary Bladder Neoplasms | 23 | 2020 | 2276 | 1.480 |
Why?
|
| Chondroitin | 3 | 2020 | 64 | 1.470 |
Why?
|
| Carcinoma, Hepatocellular | 21 | 2021 | 2299 | 1.450 |
Why?
|
| Alcoholic Beverages | 8 | 2020 | 264 | 1.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 37 | 2021 | 12293 | 1.430 |
Why?
|
| Liver Neoplasms | 27 | 2021 | 4319 | 1.420 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 9 | 2019 | 125 | 1.410 |
Why?
|
| Diverticulitis | 11 | 2021 | 182 | 1.410 |
Why?
|
| Body Size | 5 | 2017 | 462 | 1.410 |
Why?
|
| Adenocarcinoma | 32 | 2021 | 6315 | 1.400 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 8 | 2019 | 346 | 1.390 |
Why?
|
| Endometrial Neoplasms | 13 | 2020 | 1357 | 1.350 |
Why?
|
| Pathology, Molecular | 8 | 2018 | 329 | 1.340 |
Why?
|
| Glycemic Index | 12 | 2019 | 396 | 1.340 |
Why?
|
| Polymorphism, Genetic | 45 | 2014 | 4291 | 1.340 |
Why?
|
| Vitamin B Complex | 9 | 2014 | 297 | 1.340 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 12 | 2015 | 275 | 1.330 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 31 | 2021 | 2282 | 1.320 |
Why?
|
| Fatty Acids, Omega-3 | 16 | 2020 | 1387 | 1.300 |
Why?
|
| Adiponectin | 16 | 2020 | 1115 | 1.290 |
Why?
|
| Epidemiologic Studies | 17 | 2020 | 670 | 1.280 |
Why?
|
| Logistic Models | 100 | 2021 | 13314 | 1.280 |
Why?
|
| Leukocytes | 17 | 2020 | 2026 | 1.270 |
Why?
|
| Fusobacterium nucleatum | 6 | 2021 | 165 | 1.230 |
Why?
|
| Resistance Training | 3 | 2021 | 185 | 1.220 |
Why?
|
| Mendelian Randomization Analysis | 13 | 2022 | 998 | 1.210 |
Why?
|
| Overweight | 16 | 2020 | 2421 | 1.210 |
Why?
|
| Receptors, Calcitriol | 14 | 2016 | 359 | 1.210 |
Why?
|
| Yogurt | 6 | 2021 | 71 | 1.210 |
Why?
|
| Vitamin D-Binding Protein | 7 | 2020 | 131 | 1.210 |
Why?
|
| Genome-Wide Association Study | 66 | 2022 | 12626 | 1.200 |
Why?
|
| Dietary Carbohydrates | 15 | 2020 | 892 | 1.180 |
Why?
|
| Hyperglycemia | 8 | 2021 | 1380 | 1.180 |
Why?
|
| Vitamin A | 18 | 2015 | 613 | 1.150 |
Why?
|
| Postmenopause | 16 | 2021 | 2509 | 1.150 |
Why?
|
| Epidemiology | 4 | 2015 | 278 | 1.150 |
Why?
|
| Rectal Neoplasms | 15 | 2021 | 1152 | 1.140 |
Why?
|
| Cholelithiasis | 10 | 2021 | 408 | 1.130 |
Why?
|
| Waist Circumference | 16 | 2020 | 926 | 1.120 |
Why?
|
| Sex Factors | 46 | 2021 | 10547 | 1.120 |
Why?
|
| Diverticulitis, Colonic | 6 | 2021 | 138 | 1.120 |
Why?
|
| Leisure Activities | 8 | 2015 | 306 | 1.120 |
Why?
|
| Food | 4 | 2021 | 771 | 1.100 |
Why?
|
| Urination Disorders | 14 | 2011 | 240 | 1.100 |
Why?
|
| Body Height | 14 | 2020 | 1570 | 1.100 |
Why?
|
| Cause of Death | 18 | 2021 | 3725 | 1.090 |
Why?
|
| Calcifediol | 8 | 2014 | 161 | 1.080 |
Why?
|
| Risk Reduction Behavior | 14 | 2021 | 1109 | 1.070 |
Why?
|
| Antioxidants | 24 | 2020 | 1667 | 1.060 |
Why?
|
| Defecation | 5 | 2021 | 190 | 1.040 |
Why?
|
| Energy Intake | 29 | 2020 | 2129 | 1.040 |
Why?
|
| Prognosis | 106 | 2021 | 29658 | 1.030 |
Why?
|
| Genotype | 88 | 2021 | 12960 | 1.020 |
Why?
|
| Periodontal Diseases | 8 | 2020 | 452 | 1.010 |
Why?
|
| Interleukin-6 | 17 | 2019 | 3215 | 1.000 |
Why?
|
| Breast Neoplasms | 49 | 2022 | 21025 | 1.000 |
Why?
|
| Adipose Tissue | 12 | 2020 | 3301 | 0.990 |
Why?
|
| Diet, Mediterranean | 9 | 2021 | 735 | 0.990 |
Why?
|
| Vitamin E | 18 | 2018 | 872 | 0.980 |
Why?
|
| Health Surveys | 47 | 2021 | 4063 | 0.980 |
Why?
|
| Confidence Intervals | 37 | 2021 | 2932 | 0.960 |
Why?
|
| Receptors, Androgen | 12 | 2016 | 1077 | 0.950 |
Why?
|
| CpG Islands | 23 | 2020 | 1221 | 0.950 |
Why?
|
| Adenomatous Polyps | 6 | 2021 | 108 | 0.940 |
Why?
|
| alpha-Linolenic Acid | 7 | 2018 | 144 | 0.940 |
Why?
|
| PTEN Phosphohydrolase | 8 | 2021 | 1115 | 0.930 |
Why?
|
| Prostate | 14 | 2018 | 1793 | 0.930 |
Why?
|
| Causality | 9 | 2022 | 1242 | 0.920 |
Why?
|
| Eating | 19 | 2020 | 1539 | 0.920 |
Why?
|
| Erectile Dysfunction | 7 | 2020 | 452 | 0.900 |
Why?
|
| Aged, 80 and over | 133 | 2021 | 58995 | 0.900 |
Why?
|
| Nutrition Policy | 10 | 2020 | 470 | 0.890 |
Why?
|
| Obesity, Abdominal | 5 | 2019 | 374 | 0.890 |
Why?
|
| Inflammation Mediators | 9 | 2021 | 1881 | 0.870 |
Why?
|
| Anthropometry | 16 | 2019 | 1348 | 0.870 |
Why?
|
| DNA Methylation | 42 | 2020 | 4373 | 0.870 |
Why?
|
| Methionine | 16 | 2018 | 569 | 0.860 |
Why?
|
| DNA, Mitochondrial | 8 | 2020 | 858 | 0.850 |
Why?
|
| Molecular Epidemiology | 9 | 2019 | 469 | 0.850 |
Why?
|
| Sex Hormone-Binding Globulin | 11 | 2021 | 546 | 0.850 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 12 | 2021 | 1088 | 0.840 |
Why?
|
| Neoplasm Staging | 66 | 2021 | 11152 | 0.840 |
Why?
|
| Cyclooxygenase 2 | 14 | 2020 | 599 | 0.830 |
Why?
|
| Time Factors | 77 | 2021 | 40165 | 0.830 |
Why?
|
| Food, Fortified | 5 | 2021 | 189 | 0.830 |
Why?
|
| Nutrition Surveys | 17 | 2021 | 1725 | 0.810 |
Why?
|
| Age Factors | 57 | 2021 | 18416 | 0.810 |
Why?
|
| Diabetes Complications | 12 | 2020 | 1341 | 0.800 |
Why?
|
| Seafood | 8 | 2018 | 390 | 0.800 |
Why?
|
| Eggs | 4 | 2016 | 183 | 0.790 |
Why?
|
| Digestive System Neoplasms | 3 | 2021 | 81 | 0.790 |
Why?
|
| Fatty Acids, Omega-6 | 4 | 2014 | 227 | 0.790 |
Why?
|
| Folic Acid Deficiency | 6 | 2015 | 117 | 0.780 |
Why?
|
| Selenium | 10 | 2021 | 416 | 0.780 |
Why?
|
| Waist-Hip Ratio | 9 | 2020 | 516 | 0.780 |
Why?
|
| Fusobacterium Infections | 2 | 2021 | 53 | 0.780 |
Why?
|
| Flavonoids | 3 | 2017 | 445 | 0.780 |
Why?
|
| Diabetes Mellitus | 17 | 2020 | 5889 | 0.770 |
Why?
|
| Gastrointestinal Neoplasms | 5 | 2021 | 951 | 0.770 |
Why?
|
| Sunlight | 10 | 2015 | 337 | 0.760 |
Why?
|
| Fatty Acids | 11 | 2018 | 1804 | 0.760 |
Why?
|
| Age Distribution | 25 | 2021 | 2893 | 0.760 |
Why?
|
| Telomere | 12 | 2019 | 933 | 0.760 |
Why?
|
| Receptors, Calcium-Sensing | 4 | 2017 | 318 | 0.760 |
Why?
|
| Drinking | 7 | 2017 | 199 | 0.740 |
Why?
|
| Testosterone | 13 | 2021 | 2470 | 0.740 |
Why?
|
| Genetic Loci | 14 | 2021 | 2618 | 0.740 |
Why?
|
| Alopecia | 4 | 2020 | 414 | 0.740 |
Why?
|
| Estrogen Replacement Therapy | 11 | 2019 | 1206 | 0.740 |
Why?
|
| Ascorbic Acid | 16 | 2018 | 655 | 0.740 |
Why?
|
| Ethanol | 13 | 2020 | 1323 | 0.740 |
Why?
|
| Epidemiologic Methods | 10 | 2019 | 1343 | 0.730 |
Why?
|
| Tea | 9 | 2020 | 284 | 0.720 |
Why?
|
| beta Carotene | 12 | 2013 | 524 | 0.720 |
Why?
|
| Insulin Resistance | 12 | 2021 | 3959 | 0.720 |
Why?
|
| Parathyroid Hormone | 4 | 2020 | 1797 | 0.720 |
Why?
|
| Lymphoma, Non-Hodgkin | 11 | 2020 | 1375 | 0.720 |
Why?
|
| Colonoscopy | 24 | 2021 | 1387 | 0.710 |
Why?
|
| Food, Preserved | 1 | 2020 | 13 | 0.710 |
Why?
|
| Survival Analysis | 40 | 2021 | 10182 | 0.710 |
Why?
|
| Neoplasm Recurrence, Local | 22 | 2019 | 9276 | 0.710 |
Why?
|
| Tooth Loss | 8 | 2020 | 198 | 0.710 |
Why?
|
| Neovascularization, Pathologic | 7 | 2021 | 2640 | 0.700 |
Why?
|
| Proto-Oncogene Proteins B-raf | 24 | 2020 | 2053 | 0.700 |
Why?
|
| Disease Progression | 49 | 2020 | 13502 | 0.700 |
Why?
|
| Magnesium | 8 | 2019 | 810 | 0.700 |
Why?
|
| Survival Rate | 43 | 2021 | 12808 | 0.700 |
Why?
|
| Trans Fatty Acids | 5 | 2020 | 155 | 0.700 |
Why?
|
| Nutritional Requirements | 3 | 2021 | 275 | 0.700 |
Why?
|
| Choline | 7 | 2015 | 513 | 0.690 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2020 | 103 | 0.690 |
Why?
|
| Age of Onset | 11 | 2021 | 3301 | 0.680 |
Why?
|
| Randomized Controlled Trials as Topic | 28 | 2020 | 10344 | 0.680 |
Why?
|
| Models, Educational | 2 | 2012 | 373 | 0.680 |
Why?
|
| Blood Glucose | 13 | 2017 | 6381 | 0.670 |
Why?
|
| Gene Expression Regulation, Neoplastic | 27 | 2021 | 8515 | 0.660 |
Why?
|
| Pathology | 2 | 2012 | 270 | 0.660 |
Why?
|
| Diet, Fat-Restricted | 3 | 2020 | 330 | 0.660 |
Why?
|
| Dose-Response Relationship, Drug | 28 | 2020 | 10827 | 0.650 |
Why?
|
| Kidney Neoplasms | 11 | 2021 | 4312 | 0.650 |
Why?
|
| Television | 3 | 2019 | 409 | 0.640 |
Why?
|
| Dietary Proteins | 7 | 2016 | 949 | 0.640 |
Why?
|
| Trinucleotide Repeats | 8 | 2014 | 257 | 0.630 |
Why?
|
| Vitamin B 12 | 14 | 2021 | 522 | 0.630 |
Why?
|
| Postprandial Period | 4 | 2019 | 315 | 0.630 |
Why?
|
| Drinking Behavior | 3 | 2016 | 103 | 0.630 |
Why?
|
| Insulin-Like Growth Factor II | 10 | 2019 | 268 | 0.620 |
Why?
|
| Dietary Sucrose | 6 | 2018 | 244 | 0.620 |
Why?
|
| Body Weight | 16 | 2021 | 4611 | 0.620 |
Why?
|
| Cell Division | 3 | 2015 | 4463 | 0.620 |
Why?
|
| Estrogens | 8 | 2019 | 1520 | 0.620 |
Why?
|
| Cholangiocarcinoma | 6 | 2020 | 550 | 0.610 |
Why?
|
| Body Fat Distribution | 2 | 2019 | 243 | 0.610 |
Why?
|
| DNA, Neoplasm | 12 | 2015 | 1745 | 0.600 |
Why?
|
| Sex Characteristics | 10 | 2021 | 2629 | 0.600 |
Why?
|
| Body Fluid Compartments | 1 | 2017 | 50 | 0.590 |
Why?
|
| Minerals | 4 | 2016 | 283 | 0.590 |
Why?
|
| Laxatives | 2 | 2021 | 90 | 0.590 |
Why?
|
| Hypertension | 13 | 2020 | 8594 | 0.590 |
Why?
|
| Milk | 7 | 2020 | 443 | 0.590 |
Why?
|
| Bile Duct Neoplasms | 6 | 2019 | 602 | 0.580 |
Why?
|
| Nutritional Status | 10 | 2020 | 1607 | 0.580 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 6 | 2019 | 206 | 0.580 |
Why?
|
| Long Interspersed Nucleotide Elements | 12 | 2017 | 330 | 0.580 |
Why?
|
| Body Constitution | 6 | 2004 | 273 | 0.580 |
Why?
|
| Phosphorus, Dietary | 3 | 2014 | 20 | 0.580 |
Why?
|
| Beverages | 13 | 2018 | 820 | 0.580 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 10 | 2019 | 3334 | 0.570 |
Why?
|
| Genetic Variation | 23 | 2018 | 6551 | 0.560 |
Why?
|
| Epigenomics | 5 | 2017 | 936 | 0.560 |
Why?
|
| Fishes | 9 | 2019 | 601 | 0.560 |
Why?
|
| Lung Neoplasms | 27 | 2020 | 13262 | 0.560 |
Why?
|
| Betaine | 5 | 2012 | 89 | 0.560 |
Why?
|
| Puberty | 1 | 2020 | 498 | 0.550 |
Why?
|
| Lignans | 1 | 2017 | 84 | 0.550 |
Why?
|
| Intra-Abdominal Fat | 3 | 2019 | 608 | 0.550 |
Why?
|
| Interdisciplinary Communication | 2 | 2012 | 934 | 0.540 |
Why?
|
| Nutritional Sciences | 1 | 2018 | 143 | 0.540 |
Why?
|
| Cholesterol | 8 | 2019 | 2924 | 0.540 |
Why?
|
| Homocysteine | 10 | 2014 | 640 | 0.530 |
Why?
|
| Oncogene Proteins, Fusion | 9 | 2018 | 1596 | 0.530 |
Why?
|
| Carcinogens | 7 | 2016 | 449 | 0.520 |
Why?
|
| Health Occupations | 11 | 2021 | 222 | 0.510 |
Why?
|
| Serine Endopeptidases | 6 | 2020 | 1021 | 0.510 |
Why?
|
| Cathartics | 3 | 2001 | 127 | 0.510 |
Why?
|
| Cross-Sectional Studies | 48 | 2021 | 25942 | 0.510 |
Why?
|
| Europe | 21 | 2020 | 3441 | 0.510 |
Why?
|
| Blood Donors | 3 | 2015 | 343 | 0.500 |
Why?
|
| Allied Health Personnel | 2 | 2016 | 156 | 0.500 |
Why?
|
| ABO Blood-Group System | 7 | 2015 | 369 | 0.500 |
Why?
|
| Dietary Fats, Unsaturated | 4 | 2019 | 225 | 0.490 |
Why?
|
| Ferritins | 5 | 2020 | 597 | 0.490 |
Why?
|
| Prostatectomy | 15 | 2021 | 1956 | 0.490 |
Why?
|
| Micronutrients | 7 | 2021 | 381 | 0.490 |
Why?
|
| Mouth Neoplasms | 5 | 2016 | 593 | 0.480 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2011 | 1131 | 0.480 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2018 | 380 | 0.480 |
Why?
|
| DNA Copy Number Variations | 7 | 2020 | 2013 | 0.470 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2015 | 104 | 0.470 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2020 | 542 | 0.470 |
Why?
|
| Young Adult | 51 | 2021 | 58741 | 0.470 |
Why?
|
| Nitrates | 2 | 2013 | 264 | 0.470 |
Why?
|
| Prostatitis | 6 | 2015 | 102 | 0.470 |
Why?
|
| Carbon | 6 | 2014 | 669 | 0.460 |
Why?
|
| Plant Proteins | 1 | 2016 | 370 | 0.460 |
Why?
|
| Progesterone | 3 | 2019 | 742 | 0.460 |
Why?
|
| Kallikreins | 4 | 2020 | 231 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 8 | 7 | 2016 | 452 | 0.460 |
Why?
|
| Skin Neoplasms | 13 | 2021 | 5799 | 0.460 |
Why?
|
| Seasons | 13 | 2021 | 1522 | 0.450 |
Why?
|
| Metformin | 3 | 2020 | 912 | 0.450 |
Why?
|
| Watchful Waiting | 2 | 2017 | 510 | 0.450 |
Why?
|
| Social Responsibility | 1 | 2016 | 386 | 0.440 |
Why?
|
| Ovarian Neoplasms | 11 | 2020 | 4878 | 0.440 |
Why?
|
| Peptic Ulcer | 3 | 2020 | 219 | 0.440 |
Why?
|
| Models, Statistical | 11 | 2021 | 5075 | 0.430 |
Why?
|
| Early Detection of Cancer | 10 | 2021 | 3202 | 0.430 |
Why?
|
| Iron | 7 | 2021 | 1786 | 0.420 |
Why?
|
| Polypharmacy | 1 | 2015 | 307 | 0.420 |
Why?
|
| Intestinal Mucosa | 6 | 2020 | 3022 | 0.420 |
Why?
|
| Sweden | 25 | 2017 | 1381 | 0.420 |
Why?
|
| Mutagens | 4 | 2015 | 178 | 0.420 |
Why?
|
| Prescription Drugs | 2 | 2020 | 630 | 0.410 |
Why?
|
| Carcinoma, Basal Cell | 7 | 2020 | 559 | 0.410 |
Why?
|
| Nails | 3 | 2005 | 295 | 0.400 |
Why?
|
| Stem Cells | 2 | 2015 | 3523 | 0.400 |
Why?
|
| Diverticulum, Colon | 3 | 2009 | 32 | 0.390 |
Why?
|
| Immunohistochemistry | 28 | 2021 | 11071 | 0.390 |
Why?
|
| Public Health | 6 | 2020 | 2653 | 0.390 |
Why?
|
| Data Interpretation, Statistical | 6 | 2015 | 2696 | 0.380 |
Why?
|
| Physical Exertion | 2 | 2012 | 662 | 0.380 |
Why?
|
| beta Catenin | 8 | 2013 | 1043 | 0.380 |
Why?
|
| Carcinoma, Pancreatic Ductal | 6 | 2021 | 1724 | 0.380 |
Why?
|
| Longitudinal Studies | 19 | 2021 | 14495 | 0.380 |
Why?
|
| Calcitriol | 3 | 2014 | 297 | 0.380 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 1084 | 0.380 |
Why?
|
| Glutathione Transferase | 3 | 2004 | 565 | 0.380 |
Why?
|
| Colon | 12 | 2020 | 1788 | 0.370 |
Why?
|
| Weight Loss | 7 | 2021 | 2686 | 0.370 |
Why?
|
| Tumor Microenvironment | 10 | 2021 | 3844 | 0.370 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2018 | 190 | 0.370 |
Why?
|
| Prevalence | 31 | 2021 | 15687 | 0.370 |
Why?
|
| Zinc | 5 | 2011 | 689 | 0.360 |
Why?
|
| Gallbladder Neoplasms | 3 | 2017 | 190 | 0.360 |
Why?
|
| Statistics as Topic | 5 | 2014 | 2362 | 0.360 |
Why?
|
| Linkage Disequilibrium | 18 | 2021 | 1996 | 0.360 |
Why?
|
| Phosphatidylinositol 3-Kinases | 13 | 2015 | 2864 | 0.360 |
Why?
|
| Guideline Adherence | 2 | 2021 | 2283 | 0.360 |
Why?
|
| Population Surveillance | 10 | 2021 | 2608 | 0.350 |
Why?
|
| Physical Fitness | 5 | 2014 | 732 | 0.350 |
Why?
|
| Stomach Neoplasms | 8 | 2020 | 1423 | 0.350 |
Why?
|
| Smoking Cessation | 5 | 2017 | 2064 | 0.350 |
Why?
|
| Meat Products | 5 | 2019 | 96 | 0.350 |
Why?
|
| Adolescent | 48 | 2021 | 87810 | 0.350 |
Why?
|
| Self Report | 11 | 2020 | 3711 | 0.340 |
Why?
|
| Neoplasm Metastasis | 10 | 2020 | 4902 | 0.340 |
Why?
|
| Chemoprevention | 3 | 2018 | 326 | 0.340 |
Why?
|
| Women's Health | 10 | 2016 | 2056 | 0.340 |
Why?
|
| Antihypertensive Agents | 3 | 2014 | 2061 | 0.340 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 1436 | 0.340 |
Why?
|
| Superoxide Dismutase | 3 | 2014 | 594 | 0.330 |
Why?
|
| Carbonated Beverages | 5 | 2016 | 209 | 0.330 |
Why?
|
| Agaricales | 2 | 2019 | 30 | 0.330 |
Why?
|
| Colitis | 1 | 2018 | 1229 | 0.330 |
Why?
|
| Quantitative Trait Loci | 8 | 2021 | 2101 | 0.330 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 496 | 0.330 |
Why?
|
| Double-Blind Method | 27 | 2020 | 12427 | 0.330 |
Why?
|
| Health Promotion | 4 | 2019 | 2206 | 0.330 |
Why?
|
| Genetic Markers | 8 | 2015 | 2608 | 0.330 |
Why?
|
| Cod Liver Oil | 1 | 2008 | 9 | 0.330 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2015 | 412 | 0.320 |
Why?
|
| Hypolipidemic Agents | 2 | 2015 | 626 | 0.320 |
Why?
|
| Demyelinating Diseases | 1 | 2011 | 351 | 0.320 |
Why?
|
| Kaplan-Meier Estimate | 19 | 2020 | 6544 | 0.320 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2006 | 83 | 0.320 |
Why?
|
| Influenza, Human | 3 | 2011 | 1528 | 0.320 |
Why?
|
| Poultry | 5 | 2019 | 81 | 0.320 |
Why?
|
| Primary Prevention | 3 | 2020 | 1207 | 0.320 |
Why?
|
| Lipids | 4 | 2019 | 3336 | 0.310 |
Why?
|
| Regression Analysis | 23 | 2019 | 6360 | 0.310 |
Why?
|
| Carcinoma, Renal Cell | 10 | 2020 | 3218 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2016 | 385 | 0.310 |
Why?
|
| Medical History Taking | 5 | 2019 | 773 | 0.310 |
Why?
|
| Empirical Research | 1 | 2008 | 120 | 0.300 |
Why?
|
| Zea mays | 1 | 2008 | 112 | 0.300 |
Why?
|
| Brassica | 3 | 2004 | 40 | 0.300 |
Why?
|
| Urologic Diseases | 3 | 2017 | 248 | 0.300 |
Why?
|
| Nevus | 2 | 2020 | 205 | 0.300 |
Why?
|
| Eicosapentaenoic Acid | 4 | 2020 | 613 | 0.300 |
Why?
|
| Duodenal Ulcer | 4 | 2020 | 121 | 0.300 |
Why?
|
| Heart Rate | 3 | 2018 | 4179 | 0.300 |
Why?
|
| alpha-Tocopherol | 5 | 2018 | 126 | 0.300 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 15 | 2019 | 1728 | 0.300 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 4925 | 0.290 |
Why?
|
| Smad7 Protein | 2 | 2021 | 40 | 0.290 |
Why?
|
| Iron, Dietary | 5 | 2011 | 148 | 0.290 |
Why?
|
| Sigmoidoscopy | 7 | 2021 | 150 | 0.290 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2014 | 1031 | 0.290 |
Why?
|
| Tissue Array Analysis | 8 | 2016 | 551 | 0.290 |
Why?
|
| Melanoma | 5 | 2020 | 5697 | 0.290 |
Why?
|
| Mosaicism | 3 | 2016 | 466 | 0.280 |
Why?
|
| Gallbladder | 1 | 2008 | 305 | 0.280 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1523 | 0.280 |
Why?
|
| Reference Values | 9 | 2012 | 4925 | 0.280 |
Why?
|
| Coronary Disease | 18 | 2020 | 5990 | 0.280 |
Why?
|
| Health Behavior | 10 | 2020 | 2622 | 0.280 |
Why?
|
| Mutation | 34 | 2020 | 29932 | 0.280 |
Why?
|
| Research Design | 15 | 2019 | 6180 | 0.270 |
Why?
|
| Estradiol | 7 | 2021 | 1932 | 0.270 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 3 | 2014 | 321 | 0.270 |
Why?
|
| Hydroxycholecalciferols | 1 | 2006 | 44 | 0.270 |
Why?
|
| Comorbidity | 16 | 2020 | 10551 | 0.270 |
Why?
|
| Aging | 8 | 2019 | 8651 | 0.270 |
Why?
|
| Isoenzymes | 3 | 2002 | 1690 | 0.270 |
Why?
|
| Heme | 2 | 2007 | 313 | 0.270 |
Why?
|
| Nutrition Assessment | 11 | 2019 | 727 | 0.270 |
Why?
|
| Adipokines | 2 | 2020 | 311 | 0.270 |
Why?
|
| Models, Biological | 7 | 2017 | 9467 | 0.260 |
Why?
|
| Leptin | 5 | 2020 | 1591 | 0.260 |
Why?
|
| Receptors, Leptin | 3 | 2020 | 350 | 0.260 |
Why?
|
| Garlic | 2 | 2018 | 28 | 0.260 |
Why?
|
| Amines | 4 | 2009 | 281 | 0.260 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 9411 | 0.260 |
Why?
|
| Arylamine N-Acetyltransferase | 3 | 2014 | 86 | 0.260 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2019 | 557 | 0.260 |
Why?
|
| Stromal Cells | 3 | 2017 | 1326 | 0.260 |
Why?
|
| Gonorrhea | 2 | 2006 | 343 | 0.260 |
Why?
|
| Benzothiadiazines | 1 | 2005 | 31 | 0.250 |
Why?
|
| Trichomonas Infections | 3 | 2012 | 41 | 0.250 |
Why?
|
| Diet Records | 10 | 2018 | 427 | 0.250 |
Why?
|
| Progestins | 2 | 2019 | 302 | 0.250 |
Why?
|
| Severity of Illness Index | 13 | 2016 | 15840 | 0.250 |
Why?
|
| Genetic Association Studies | 11 | 2017 | 2717 | 0.250 |
Why?
|
| Hormone Replacement Therapy | 1 | 2011 | 755 | 0.250 |
Why?
|
| Esophageal Neoplasms | 5 | 2020 | 1648 | 0.250 |
Why?
|
| Phytotherapy | 2 | 2016 | 295 | 0.250 |
Why?
|
| Ultraviolet Rays | 6 | 2016 | 1078 | 0.250 |
Why?
|
| Trans-Activators | 4 | 2016 | 2860 | 0.250 |
Why?
|
| Isoflavones | 2 | 2016 | 136 | 0.250 |
Why?
|
| Survivors | 3 | 2015 | 2375 | 0.250 |
Why?
|
| Alleles | 18 | 2017 | 6898 | 0.250 |
Why?
|
| Linear Models | 11 | 2018 | 5877 | 0.250 |
Why?
|
| Sweetening Agents | 3 | 2018 | 290 | 0.240 |
Why?
|
| SEER Program | 4 | 2021 | 1530 | 0.240 |
Why?
|
| Thymidylate Synthase | 1 | 2004 | 74 | 0.240 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2005 | 78 | 0.240 |
Why?
|
| Rectum | 7 | 2020 | 895 | 0.240 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 13 | 2016 | 895 | 0.240 |
Why?
|
| Growth Differentiation Factor 15 | 3 | 2015 | 196 | 0.240 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2019 | 264 | 0.240 |
Why?
|
| Family Health | 5 | 2017 | 1257 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 2021 | 313 | 0.230 |
Why?
|
| Hypoglycemic Agents | 5 | 2021 | 3150 | 0.230 |
Why?
|
| Cholecystitis | 1 | 2005 | 181 | 0.230 |
Why?
|
| Influenza A virus | 1 | 2008 | 457 | 0.230 |
Why?
|
| Gene Silencing | 3 | 2010 | 1513 | 0.230 |
Why?
|
| Animals | 52 | 2021 | 167963 | 0.230 |
Why?
|
| Jews | 2 | 2019 | 364 | 0.230 |
Why?
|
| Evidence-Based Medicine | 3 | 2013 | 3696 | 0.230 |
Why?
|
| Disease Susceptibility | 7 | 2021 | 1791 | 0.230 |
Why?
|
| Beer | 4 | 2020 | 134 | 0.230 |
Why?
|
| Pandemics | 2 | 2021 | 8624 | 0.230 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 11 | 2017 | 3804 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 7475 | 0.220 |
Why?
|
| Cotinine | 3 | 2018 | 203 | 0.220 |
Why?
|
| Wine | 4 | 2020 | 167 | 0.220 |
Why?
|
| Mass Screening | 11 | 2021 | 5423 | 0.220 |
Why?
|
| Heterocyclic Compounds | 2 | 2009 | 247 | 0.220 |
Why?
|
| Receptors, Adiponectin | 2 | 2015 | 81 | 0.220 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2003 | 113 | 0.220 |
Why?
|
| Fructose | 3 | 2004 | 287 | 0.220 |
Why?
|
| ras Proteins | 8 | 2012 | 1052 | 0.210 |
Why?
|
| Predictive Value of Tests | 18 | 2017 | 15289 | 0.210 |
Why?
|
| Patient Compliance | 4 | 2018 | 2688 | 0.210 |
Why?
|
| Dinucleotide Repeats | 1 | 2002 | 29 | 0.210 |
Why?
|
| Cooking | 4 | 2015 | 311 | 0.210 |
Why?
|
| Microsatellite Repeats | 3 | 2014 | 786 | 0.210 |
Why?
|
| Gene Dosage | 3 | 2016 | 1218 | 0.210 |
Why?
|
| Databases, Factual | 12 | 2021 | 8035 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2016 | 193 | 0.210 |
Why?
|
| China | 5 | 2021 | 2339 | 0.210 |
Why?
|
| Pelvic Pain | 2 | 2015 | 298 | 0.210 |
Why?
|
| Sex | 1 | 2002 | 52 | 0.210 |
Why?
|
| Colitis, Ulcerative | 4 | 2020 | 1919 | 0.210 |
Why?
|
| Receptors, Estrogen | 6 | 2019 | 2210 | 0.210 |
Why?
|
| Menarche | 4 | 2018 | 529 | 0.210 |
Why?
|
| Chronic Disease | 11 | 2021 | 9287 | 0.200 |
Why?
|
| Gallbladder Diseases | 1 | 2003 | 137 | 0.200 |
Why?
|
| Energy Metabolism | 6 | 2018 | 2869 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2012 | 580 | 0.200 |
Why?
|
| Metabolomics | 4 | 2021 | 1628 | 0.200 |
Why?
|
| Multiple Myeloma | 6 | 2020 | 5130 | 0.200 |
Why?
|
| Principal Component Analysis | 5 | 2020 | 940 | 0.200 |
Why?
|
| Sunburn | 2 | 2021 | 156 | 0.200 |
Why?
|
| Xanthophylls | 6 | 2012 | 95 | 0.200 |
Why?
|
| Muscle Strength | 2 | 2021 | 619 | 0.200 |
Why?
|
| Blood Pressure | 4 | 2017 | 8525 | 0.200 |
Why?
|
| Bone Neoplasms | 3 | 2015 | 2532 | 0.200 |
Why?
|
| HIV Wasting Syndrome | 2 | 2012 | 97 | 0.200 |
Why?
|
| Biological Availability | 2 | 2018 | 395 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2016 | 2802 | 0.200 |
Why?
|
| Neoplasm Invasiveness | 8 | 2021 | 3618 | 0.200 |
Why?
|
| Respiratory Tract Infections | 2 | 2011 | 1007 | 0.200 |
Why?
|
| Republic of Korea | 3 | 2020 | 566 | 0.190 |
Why?
|
| Immunologic Factors | 2 | 2018 | 1588 | 0.190 |
Why?
|
| Receptors, Somatostatin | 2 | 2014 | 136 | 0.190 |
Why?
|
| Neoplasms, Second Primary | 3 | 2021 | 1056 | 0.190 |
Why?
|
| Nitrosamines | 3 | 2019 | 87 | 0.190 |
Why?
|
| Sulfur Compounds | 1 | 2021 | 33 | 0.190 |
Why?
|
| Disease-Free Survival | 11 | 2019 | 6828 | 0.190 |
Why?
|
| Premenopause | 3 | 2015 | 1038 | 0.190 |
Why?
|
| Genome, Human | 6 | 2020 | 4417 | 0.190 |
Why?
|
| Somatotypes | 1 | 2021 | 41 | 0.190 |
Why?
|
| Metabolome | 2 | 2020 | 982 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 6 | 2011 | 5785 | 0.190 |
Why?
|
| Constipation | 2 | 2021 | 561 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2016 | 635 | 0.190 |
Why?
|
| Receptor, Insulin | 2 | 2018 | 836 | 0.190 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2020 | 296 | 0.190 |
Why?
|
| Monosaccharides | 1 | 2021 | 69 | 0.190 |
Why?
|
| Alkylating Agents | 1 | 2021 | 133 | 0.180 |
Why?
|
| Hair Dyes | 1 | 2020 | 30 | 0.180 |
Why?
|
| Meta-Analysis as Topic | 7 | 2021 | 1376 | 0.180 |
Why?
|
| Human Growth Hormone | 2 | 2003 | 638 | 0.180 |
Why?
|
| Fish Oils | 4 | 2019 | 482 | 0.180 |
Why?
|
| Epigenesis, Genetic | 8 | 2016 | 3758 | 0.180 |
Why?
|
| Menopause | 5 | 2020 | 1640 | 0.180 |
Why?
|
| Contraceptives, Oral | 4 | 2016 | 554 | 0.180 |
Why?
|
| Telomerase | 2 | 2016 | 746 | 0.180 |
Why?
|
| Squalene Monooxygenase | 2 | 2017 | 11 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 14 | 2016 | 6068 | 0.180 |
Why?
|
| Gastrointestinal Transit | 1 | 2001 | 99 | 0.180 |
Why?
|
| Lutein | 5 | 2012 | 122 | 0.170 |
Why?
|
| Walking | 3 | 2020 | 1189 | 0.170 |
Why?
|
| Desiccation | 1 | 2020 | 78 | 0.170 |
Why?
|
| Trichomonas vaginalis | 3 | 2012 | 70 | 0.170 |
Why?
|
| Diet Therapy | 1 | 2021 | 151 | 0.170 |
Why?
|
| Endoribonucleases | 2 | 2013 | 229 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2012 | 358 | 0.170 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 10181 | 0.170 |
Why?
|
| Adolescent Behavior | 2 | 2021 | 1175 | 0.170 |
Why?
|
| Food Handling | 5 | 2015 | 155 | 0.170 |
Why?
|
| Phenotype | 19 | 2020 | 16546 | 0.170 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2017 | 586 | 0.170 |
Why?
|
| Up-Regulation | 7 | 2019 | 4122 | 0.170 |
Why?
|
| Sodium, Dietary | 3 | 2021 | 425 | 0.170 |
Why?
|
| Cyclin D1 | 2 | 2015 | 451 | 0.170 |
Why?
|
| Parity | 3 | 2003 | 925 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 1796 | 0.170 |
Why?
|
| Gastrointestinal Motility | 1 | 2021 | 234 | 0.170 |
Why?
|
| Genes, ras | 2 | 2020 | 655 | 0.170 |
Why?
|
| Reproducibility of Results | 19 | 2016 | 20080 | 0.160 |
Why?
|
| Erythrocyte Membrane | 1 | 2020 | 439 | 0.160 |
Why?
|
| Helicobacter pylori | 2 | 2018 | 377 | 0.160 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 56 | 0.160 |
Why?
|
| Diet, Vegetarian | 1 | 2021 | 180 | 0.160 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 1758 | 0.160 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 167 | 0.160 |
Why?
|
| Estrone | 1 | 2020 | 232 | 0.160 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2018 | 174 | 0.160 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2020 | 190 | 0.160 |
Why?
|
| Signal Transduction | 11 | 2019 | 23376 | 0.160 |
Why?
|
| United States Food and Drug Administration | 1 | 2007 | 1677 | 0.160 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 3610 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 10 | 2016 | 4490 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2021 | 1810 | 0.160 |
Why?
|
| Boston | 17 | 2015 | 9280 | 0.160 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1999 | 318 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2020 | 2421 | 0.150 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2020 | 867 | 0.150 |
Why?
|
| Arachidonic Acid | 1 | 2020 | 433 | 0.150 |
Why?
|
| Child | 23 | 2021 | 79806 | 0.150 |
Why?
|
| Selection Bias | 2 | 2017 | 358 | 0.150 |
Why?
|
| Somatomedins | 2 | 2008 | 178 | 0.150 |
Why?
|
| Prostatic Diseases | 2 | 2011 | 57 | 0.150 |
Why?
|
| Child, Preschool | 14 | 2021 | 42063 | 0.150 |
Why?
|
| Polyps | 1 | 2020 | 197 | 0.150 |
Why?
|
| Birth Weight | 3 | 2021 | 2097 | 0.150 |
Why?
|
| Brazil | 5 | 2020 | 1218 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 4 | 1999 | 61 | 0.150 |
Why?
|
| Mitochondria | 3 | 2020 | 3600 | 0.150 |
Why?
|
| Prostatism | 2 | 2008 | 14 | 0.150 |
Why?
|
| Chi-Square Distribution | 5 | 2011 | 3465 | 0.150 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2021 | 261 | 0.150 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 17 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 2 | 2021 | 748 | 0.150 |
Why?
|
| Skinfold Thickness | 1 | 2017 | 158 | 0.150 |
Why?
|
| Reproductive History | 2 | 2003 | 210 | 0.150 |
Why?
|
| Docosahexaenoic Acids | 3 | 2018 | 912 | 0.150 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2017 | 28 | 0.150 |
Why?
|
| Treatment Outcome | 25 | 2019 | 65017 | 0.150 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2017 | 33 | 0.150 |
Why?
|
| Intestinal Polyps | 1 | 1997 | 104 | 0.150 |
Why?
|
| Phaseolus | 1 | 2017 | 16 | 0.150 |
Why?
|
| Exercise Therapy | 2 | 2015 | 919 | 0.140 |
Why?
|
| Oxidative Stress | 8 | 2020 | 3106 | 0.140 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2017 | 93 | 0.140 |
Why?
|
| Chromosome Mapping | 5 | 2018 | 4625 | 0.140 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2011 | 100 | 0.140 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2017 | 89 | 0.140 |
Why?
|
| Genes, Neoplasm | 2 | 2011 | 370 | 0.140 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2018 | 92 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2020 | 4024 | 0.140 |
Why?
|
| Smoke | 1 | 2019 | 236 | 0.140 |
Why?
|
| Periodontitis | 3 | 2013 | 560 | 0.140 |
Why?
|
| Metabolic Equivalent | 1 | 2016 | 14 | 0.140 |
Why?
|
| Registries | 17 | 2021 | 8469 | 0.140 |
Why?
|
| Tanzania | 8 | 2013 | 1383 | 0.140 |
Why?
|
| Gene Frequency | 9 | 2018 | 3615 | 0.140 |
Why?
|
| Tumor Burden | 2 | 2020 | 1895 | 0.140 |
Why?
|
| Antibodies, Protozoan | 2 | 2009 | 251 | 0.140 |
Why?
|
| Functional Food | 1 | 2016 | 20 | 0.140 |
Why?
|
| BRCA1 Protein | 2 | 2016 | 1147 | 0.140 |
Why?
|
| Blood Sedimentation | 2 | 2015 | 234 | 0.140 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.140 |
Why?
|
| Cholesterol, HDL | 3 | 2019 | 1817 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2018 | 3775 | 0.140 |
Why?
|
| Fasting | 4 | 2017 | 1603 | 0.140 |
Why?
|
| Sex Distribution | 8 | 2020 | 2295 | 0.140 |
Why?
|
| Nursing Research | 1 | 2017 | 80 | 0.140 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2016 | 113 | 0.130 |
Why?
|
| Soy Foods | 1 | 2016 | 44 | 0.130 |
Why?
|
| Physicians | 13 | 2015 | 4591 | 0.130 |
Why?
|
| Fluorouracil | 2 | 2019 | 1631 | 0.130 |
Why?
|
| Drug Administration Schedule | 6 | 2021 | 4899 | 0.130 |
Why?
|
| Riboflavin | 1 | 2016 | 105 | 0.130 |
Why?
|
| Tricarboxylic Acids | 1 | 2016 | 26 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2014 | 1173 | 0.130 |
Why?
|
| Hospital Mortality | 4 | 2015 | 5425 | 0.130 |
Why?
|
| Epistasis, Genetic | 3 | 2016 | 350 | 0.130 |
Why?
|
| Hormones | 1 | 2020 | 867 | 0.130 |
Why?
|
| Triglycerides | 3 | 2019 | 2476 | 0.130 |
Why?
|
| Androgen Antagonists | 3 | 2016 | 1442 | 0.130 |
Why?
|
| Urinary Incontinence | 2 | 2011 | 495 | 0.130 |
Why?
|
| Lipoproteins, HDL | 1 | 2020 | 667 | 0.130 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2016 | 37 | 0.130 |
Why?
|
| Seeds | 1 | 2016 | 120 | 0.130 |
Why?
|
| Barrett Esophagus | 2 | 2011 | 490 | 0.130 |
Why?
|
| Asthma | 1 | 2015 | 6172 | 0.130 |
Why?
|
| Haplotypes | 10 | 2014 | 2764 | 0.130 |
Why?
|
| Plants, Edible | 1 | 2015 | 29 | 0.130 |
Why?
|
| Models, Theoretical | 3 | 2021 | 3562 | 0.130 |
Why?
|
| Radioimmunoassay | 2 | 2014 | 866 | 0.130 |
Why?
|
| Biopsy | 6 | 2017 | 6771 | 0.130 |
Why?
|
| MicroRNAs | 3 | 2016 | 3790 | 0.130 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2013 | 1894 | 0.130 |
Why?
|
| Sucrose | 1 | 2016 | 156 | 0.130 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 2 | 2012 | 57 | 0.130 |
Why?
|
| Critical Illness | 3 | 2014 | 2709 | 0.130 |
Why?
|
| Sensitivity and Specificity | 11 | 2017 | 14660 | 0.130 |
Why?
|
| Thymine | 1 | 2015 | 69 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 127 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 3 | 2017 | 1174 | 0.130 |
Why?
|
| Nicotine | 2 | 2019 | 677 | 0.130 |
Why?
|
| Nonsteroidal Anti-Androgens | 1 | 2015 | 9 | 0.130 |
Why?
|
| Population Groups | 1 | 2016 | 211 | 0.130 |
Why?
|
| Plant Extracts | 2 | 2016 | 496 | 0.120 |
Why?
|
| Growth | 1 | 2017 | 365 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 2828 | 0.120 |
Why?
|
| International Cooperation | 2 | 2019 | 1433 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2016 | 412 | 0.120 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2016 | 1628 | 0.120 |
Why?
|
| HIV Infections | 8 | 2013 | 17165 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2019 | 4550 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 1 | 2020 | 551 | 0.120 |
Why?
|
| Retrospective Studies | 26 | 2021 | 80372 | 0.120 |
Why?
|
| Myocardial Infarction | 7 | 2017 | 11891 | 0.120 |
Why?
|
| Receptors, LDL | 1 | 2017 | 488 | 0.120 |
Why?
|
| Nicotinic Agonists | 1 | 2017 | 265 | 0.120 |
Why?
|
| Glycine N-Methyltransferase | 1 | 2014 | 2 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 4 | 2021 | 7408 | 0.120 |
Why?
|
| Biological Specimen Banks | 4 | 2021 | 783 | 0.120 |
Why?
|
| Wet Macular Degeneration | 1 | 2017 | 162 | 0.120 |
Why?
|
| Prediabetic State | 1 | 2020 | 550 | 0.120 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2016 | 235 | 0.120 |
Why?
|
| TRPM Cation Channels | 1 | 2015 | 139 | 0.120 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2014 | 31 | 0.120 |
Why?
|
| Helicobacter Infections | 1 | 2018 | 386 | 0.120 |
Why?
|
| Tumor Escape | 1 | 2017 | 370 | 0.120 |
Why?
|
| Hypercalcemia | 2 | 2014 | 421 | 0.120 |
Why?
|
| Diet, Gluten-Free | 1 | 2017 | 280 | 0.120 |
Why?
|
| Smad4 Protein | 1 | 2015 | 191 | 0.120 |
Why?
|
| Cross Infection | 2 | 2014 | 1434 | 0.120 |
Why?
|
| Work Schedule Tolerance | 1 | 2018 | 551 | 0.120 |
Why?
|
| Cytosine | 1 | 2015 | 212 | 0.120 |
Why?
|
| Quality of Life | 5 | 2020 | 13308 | 0.120 |
Why?
|
| Calcium Signaling | 1 | 2019 | 732 | 0.120 |
Why?
|
| Anxiety | 2 | 2020 | 4538 | 0.120 |
Why?
|
| Hospitalization | 7 | 2015 | 10790 | 0.120 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 321 | 0.120 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2016 | 184 | 0.110 |
Why?
|
| Epoxide Hydrolases | 2 | 2005 | 122 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 226 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2019 | 805 | 0.110 |
Why?
|
| Time | 2 | 2017 | 545 | 0.110 |
Why?
|
| Hydrochlorothiazide | 1 | 2014 | 94 | 0.110 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 311 | 0.110 |
Why?
|
| Inheritance Patterns | 1 | 2016 | 340 | 0.110 |
Why?
|
| Crohn Disease | 2 | 2020 | 2275 | 0.110 |
Why?
|
| Bone Density Conservation Agents | 3 | 2014 | 796 | 0.110 |
Why?
|
| Developed Countries | 3 | 2001 | 442 | 0.110 |
Why?
|
| Genetic Heterogeneity | 2 | 2012 | 724 | 0.110 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2014 | 144 | 0.110 |
Why?
|
| Prostaglandin Antagonists | 1 | 2013 | 28 | 0.110 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2005 | 253 | 0.110 |
Why?
|
| Erythrocytes | 2 | 2020 | 2415 | 0.110 |
Why?
|
| Iceland | 3 | 2019 | 184 | 0.110 |
Why?
|
| Osteopontin | 1 | 2015 | 302 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 617 | 0.110 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2013 | 18 | 0.110 |
Why?
|
| Estrogen Receptor beta | 2 | 2020 | 168 | 0.110 |
Why?
|
| Citrus | 1 | 2013 | 44 | 0.110 |
Why?
|
| Pyridoxal Phosphate | 3 | 2013 | 124 | 0.110 |
Why?
|
| Fatigue | 1 | 2020 | 1544 | 0.110 |
Why?
|
| Minority Health | 1 | 2014 | 81 | 0.110 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 179 | 0.110 |
Why?
|
| Glioma | 4 | 2010 | 3420 | 0.110 |
Why?
|
| Probability | 6 | 2017 | 2475 | 0.110 |
Why?
|
| Germ-Line Mutation | 4 | 2020 | 1841 | 0.110 |
Why?
|
| Glucose | 1 | 2005 | 4351 | 0.110 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2015 | 687 | 0.110 |
Why?
|
| Prostaglandins | 1 | 2014 | 398 | 0.110 |
Why?
|
| National Cancer Institute (U.S.) | 4 | 2019 | 296 | 0.110 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2014 | 117 | 0.110 |
Why?
|
| Measles Vaccine | 1 | 2013 | 81 | 0.110 |
Why?
|
| Demography | 2 | 2015 | 1650 | 0.110 |
Why?
|
| Cyclin D2 | 1 | 2012 | 98 | 0.110 |
Why?
|
| Liver Cirrhosis | 2 | 2020 | 1931 | 0.100 |
Why?
|
| Lymphocyte Count | 4 | 2016 | 780 | 0.100 |
Why?
|
| Lymphoma, B-Cell | 2 | 2017 | 935 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2013 | 2569 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 68 | 0.100 |
Why?
|
| Quinoxalines | 2 | 2015 | 297 | 0.100 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 442 | 0.100 |
Why?
|
| Mental Recall | 3 | 1998 | 1206 | 0.100 |
Why?
|
| Chromosomal Instability | 1 | 2013 | 177 | 0.100 |
Why?
|
| Genomics | 4 | 2016 | 5794 | 0.100 |
Why?
|
| Leukemia | 1 | 2020 | 1520 | 0.100 |
Why?
|
| Japan | 2 | 2013 | 1369 | 0.100 |
Why?
|
| Men | 1 | 2012 | 64 | 0.100 |
Why?
|
| Genetic Pleiotropy | 1 | 2013 | 181 | 0.100 |
Why?
|
| Vasculitis | 1 | 2016 | 523 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 995 | 0.100 |
Why?
|
| Computational Biology | 4 | 2017 | 3505 | 0.100 |
Why?
|
| Arthritis, Psoriatic | 1 | 2015 | 219 | 0.100 |
Why?
|
| Breast Diseases | 1 | 2015 | 443 | 0.100 |
Why?
|
| Preventive Medicine | 2 | 2007 | 250 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 2180 | 0.100 |
Why?
|
| Diet, Reducing | 1 | 2015 | 488 | 0.100 |
Why?
|
| Major Histocompatibility Complex | 1 | 2015 | 928 | 0.100 |
Why?
|
| Urban Population | 2 | 2017 | 2022 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 3 | 2021 | 524 | 0.100 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 3 | 2009 | 70 | 0.100 |
Why?
|
| Hemeproteins | 1 | 2011 | 61 | 0.100 |
Why?
|
| Tuberculin Test | 1 | 2012 | 206 | 0.100 |
Why?
|
| Apoptosis | 5 | 2018 | 9501 | 0.100 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 587 | 0.100 |
Why?
|
| Multiple Sclerosis | 3 | 2011 | 3204 | 0.100 |
Why?
|
| Acrylamide | 1 | 2011 | 59 | 0.100 |
Why?
|
| Snoring | 1 | 2013 | 206 | 0.100 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 1736 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 1999 | 3726 | 0.090 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2005 | 218 | 0.090 |
Why?
|
| Glycine | 1 | 2014 | 662 | 0.090 |
Why?
|
| Publication Bias | 1 | 2012 | 162 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 1764 | 0.090 |
Why?
|
| Sepsis | 3 | 2014 | 2592 | 0.090 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2010 | 28 | 0.090 |
Why?
|
| Membrane Proteins | 5 | 2021 | 7850 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2012 | 162 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 1035 | 0.090 |
Why?
|
| Adult Children | 1 | 2011 | 103 | 0.090 |
Why?
|
| Pregnancy | 11 | 2021 | 29749 | 0.090 |
Why?
|
| Male Urogenital Diseases | 1 | 2010 | 48 | 0.090 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2010 | 40 | 0.090 |
Why?
|
| Databases, Genetic | 4 | 2020 | 1738 | 0.090 |
Why?
|
| Racemases and Epimerases | 1 | 2011 | 112 | 0.090 |
Why?
|
| Social Support | 2 | 2017 | 2145 | 0.090 |
Why?
|
| Genes, p16 | 1 | 2011 | 159 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2010 | 48 | 0.090 |
Why?
|
| Antibodies, Viral | 3 | 2013 | 3143 | 0.090 |
Why?
|
| Brain Neoplasms | 6 | 2020 | 8986 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2018 | 4357 | 0.090 |
Why?
|
| Clinical Trials as Topic | 5 | 2011 | 8056 | 0.090 |
Why?
|
| Avitaminosis | 1 | 2010 | 35 | 0.090 |
Why?
|
| Interdisciplinary Studies | 1 | 2010 | 86 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 726 | 0.090 |
Why?
|
| Bacteria | 1 | 2021 | 2199 | 0.090 |
Why?
|
| Carbohydrate Metabolism | 1 | 2011 | 262 | 0.090 |
Why?
|
| Health Status Disparities | 2 | 2014 | 1830 | 0.090 |
Why?
|
| Statistics, Nonparametric | 5 | 2007 | 2852 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2011 | 2125 | 0.090 |
Why?
|
| Lymphoma, Follicular | 1 | 2014 | 453 | 0.090 |
Why?
|
| Disease | 1 | 2015 | 671 | 0.090 |
Why?
|
| Food Contamination | 1 | 2011 | 192 | 0.090 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2014 | 384 | 0.090 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2010 | 56 | 0.090 |
Why?
|
| RNA, Messenger | 5 | 2017 | 12766 | 0.090 |
Why?
|
| Digoxin | 1 | 2011 | 247 | 0.090 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2006 | 628 | 0.090 |
Why?
|
| DNA Modification Methylases | 1 | 2010 | 209 | 0.090 |
Why?
|
| Nephrolithiasis | 1 | 2011 | 114 | 0.090 |
Why?
|
| Genes, bcl-1 | 1 | 2009 | 11 | 0.090 |
Why?
|
| Receptors, Progesterone | 2 | 2012 | 1130 | 0.090 |
Why?
|
| Acromegaly | 2 | 2003 | 306 | 0.090 |
Why?
|
| Dimethylnitrosamine | 1 | 2009 | 17 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 377 | 0.080 |
Why?
|
| Carbohydrates | 1 | 2011 | 388 | 0.080 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1002 | 0.080 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2009 | 24 | 0.080 |
Why?
|
| North America | 6 | 2010 | 1284 | 0.080 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 2 | 1999 | 28 | 0.080 |
Why?
|
| Gene Fusion | 1 | 2012 | 354 | 0.080 |
Why?
|
| Placebos | 4 | 2017 | 1668 | 0.080 |
Why?
|
| Latent Tuberculosis | 1 | 2012 | 224 | 0.080 |
Why?
|
| Community-Acquired Infections | 1 | 2013 | 461 | 0.080 |
Why?
|
| Incretins | 1 | 2010 | 103 | 0.080 |
Why?
|
| Urodynamics | 1 | 2011 | 346 | 0.080 |
Why?
|
| Gene Expression | 3 | 2020 | 7588 | 0.080 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2013 | 831 | 0.080 |
Why?
|
| Genetics, Population | 2 | 2007 | 930 | 0.080 |
Why?
|
| Aromatase | 1 | 2009 | 147 | 0.080 |
Why?
|
| Acetaminophen | 2 | 2007 | 553 | 0.080 |
Why?
|
| Stathmin | 1 | 2009 | 70 | 0.080 |
Why?
|
| Nitrites | 1 | 2009 | 159 | 0.080 |
Why?
|
| Sleep | 2 | 2017 | 4751 | 0.080 |
Why?
|
| Esophagoscopy | 1 | 2011 | 390 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2014 | 4938 | 0.080 |
Why?
|
| Steroid Hydroxylases | 3 | 2014 | 96 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2014 | 1368 | 0.080 |
Why?
|
| DNA Repair Enzymes | 1 | 2010 | 345 | 0.080 |
Why?
|
| Philadelphia | 1 | 2009 | 265 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1895 | 0.080 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2009 | 83 | 0.080 |
Why?
|
| Sulfonylurea Compounds | 1 | 2010 | 221 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 330 | 0.080 |
Why?
|
| Drug Antagonism | 1 | 2008 | 52 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2008 | 120 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2009 | 276 | 0.080 |
Why?
|
| Epidemiologic Measurements | 1 | 2008 | 22 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2009 | 283 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 789 | 0.080 |
Why?
|
| Imidazoles | 2 | 2015 | 1180 | 0.080 |
Why?
|
| Orchiectomy | 1 | 2010 | 470 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2008 | 5251 | 0.080 |
Why?
|
| Fucosyltransferases | 1 | 2008 | 117 | 0.080 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2008 | 52 | 0.080 |
Why?
|
| Calcium Carbonate | 1 | 2008 | 62 | 0.080 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2007 | 12 | 0.080 |
Why?
|
| Lipotropic Agents | 1 | 2007 | 13 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1398 | 0.080 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2007 | 29 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2018 | 3529 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 2471 | 0.080 |
Why?
|
| Palmitic Acid | 1 | 2008 | 149 | 0.080 |
Why?
|
| Propionibacterium acnes | 1 | 2007 | 65 | 0.080 |
Why?
|
| Cataract Extraction | 2 | 2004 | 465 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 138 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1403 | 0.070 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 389 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2012 | 2919 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 616 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2016 | 878 | 0.070 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2007 | 49 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2011 | 662 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 5 | 2012 | 4713 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2015 | 2435 | 0.070 |
Why?
|
| Fractures, Bone | 3 | 2010 | 2041 | 0.070 |
Why?
|
| One-Carbon Group Transferases | 1 | 2007 | 6 | 0.070 |
Why?
|
| Androstane-3,17-diol | 1 | 2007 | 20 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2138 | 0.070 |
Why?
|
| History, 21st Century | 3 | 2019 | 1575 | 0.070 |
Why?
|
| Flavanones | 2 | 2019 | 74 | 0.070 |
Why?
|
| Diuretics | 2 | 2014 | 613 | 0.070 |
Why?
|
| Asia | 2 | 2020 | 620 | 0.070 |
Why?
|
| Urinary Tract | 1 | 2010 | 309 | 0.070 |
Why?
|
| Tetracycline | 1 | 2007 | 220 | 0.070 |
Why?
|
| Lymphatic Metastasis | 2 | 2012 | 2943 | 0.070 |
Why?
|
| Visual Acuity | 1 | 2017 | 2643 | 0.070 |
Why?
|
| Patient Admission | 1 | 2015 | 1386 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 465 | 0.070 |
Why?
|
| Socioeconomic Factors | 5 | 2019 | 7806 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11712 | 0.070 |
Why?
|
| Acne Vulgaris | 2 | 2013 | 355 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2014 | 557 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 600 | 0.070 |
Why?
|
| Australia | 3 | 2018 | 1289 | 0.070 |
Why?
|
| Glutamine | 2 | 2021 | 576 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2018 | 10446 | 0.070 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 814 | 0.070 |
Why?
|
| Review Literature as Topic | 1 | 2009 | 349 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2062 | 0.070 |
Why?
|
| Human papillomavirus 18 | 1 | 2007 | 125 | 0.070 |
Why?
|
| Sirtuins | 1 | 2009 | 320 | 0.070 |
Why?
|
| Ultraviolet Therapy | 1 | 2006 | 84 | 0.070 |
Why?
|
| Genes, BRCA1 | 1 | 2010 | 765 | 0.070 |
Why?
|
| Premature Birth | 1 | 2018 | 1771 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 621 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1827 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 2 | 2006 | 998 | 0.070 |
Why?
|
| Bayes Theorem | 3 | 2020 | 2326 | 0.070 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2005 | 55 | 0.070 |
Why?
|
| Biosynthetic Pathways | 1 | 2006 | 135 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 3 | 2015 | 1705 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 907 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 484 | 0.060 |
Why?
|
| Leukoplakia, Oral | 1 | 2006 | 77 | 0.060 |
Why?
|
| Interviews as Topic | 5 | 2011 | 2659 | 0.060 |
Why?
|
| Chlamydia trachomatis | 1 | 2007 | 238 | 0.060 |
Why?
|
| Thinness | 1 | 2009 | 491 | 0.060 |
Why?
|
| ROC Curve | 4 | 2018 | 3568 | 0.060 |
Why?
|
| Chromatin | 1 | 2017 | 2938 | 0.060 |
Why?
|
| Herpesvirus 8, Human | 1 | 2007 | 255 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2007 | 265 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 2417 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2018 | 430 | 0.060 |
Why?
|
| Diverticulum | 2 | 1998 | 137 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2005 | 46 | 0.060 |
Why?
|
| California | 3 | 2018 | 1416 | 0.060 |
Why?
|
| Mongolia | 2 | 2017 | 93 | 0.060 |
Why?
|
| Algorithms | 4 | 2018 | 13981 | 0.060 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2007 | 343 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2009 | 517 | 0.060 |
Why?
|
| Proteins | 3 | 2018 | 6029 | 0.060 |
Why?
|
| Urinary Bladder | 1 | 2011 | 1166 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2010 | 1153 | 0.060 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2015 | 16 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2005 | 130 | 0.060 |
Why?
|
| Infant Mortality | 1 | 2009 | 757 | 0.060 |
Why?
|
| Fructosamine | 1 | 2004 | 14 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 4 | 1999 | 1501 | 0.060 |
Why?
|
| Skin Pigmentation | 1 | 2006 | 277 | 0.060 |
Why?
|
| Syphilis | 1 | 2006 | 241 | 0.060 |
Why?
|
| Penetrance | 1 | 2005 | 388 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 3707 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2008 | 1516 | 0.060 |
Why?
|
| Netherlands | 1 | 2008 | 2213 | 0.060 |
Why?
|
| Massachusetts | 4 | 2021 | 8803 | 0.060 |
Why?
|
| Finland | 3 | 2010 | 603 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2015 | 2890 | 0.050 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2014 | 58 | 0.050 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2009 | 812 | 0.050 |
Why?
|
| Delirium | 1 | 2015 | 1663 | 0.050 |
Why?
|
| Transferrin | 2 | 2020 | 284 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 13630 | 0.050 |
Why?
|
| Heart | 1 | 2016 | 4393 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2009 | 1572 | 0.050 |
Why?
|
| Cell Growth Processes | 2 | 2014 | 384 | 0.050 |
Why?
|
| Depression | 2 | 2017 | 8044 | 0.050 |
Why?
|
| Arginine | 1 | 2006 | 934 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2010 | 2208 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 4573 | 0.050 |
Why?
|
| Proteomics | 1 | 2016 | 3817 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2003 | 1544 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2018 | 2648 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2009 | 1348 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2003 | 617 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 660 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2018 | 4642 | 0.050 |
Why?
|
| T-Box Domain Proteins | 2 | 2016 | 468 | 0.050 |
Why?
|
| Toes | 2 | 2003 | 209 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 2003 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2015 | 6218 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 816 | 0.050 |
Why?
|
| Endpoint Determination | 2 | 2015 | 597 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2009 | 2611 | 0.050 |
Why?
|
| Combined Modality Therapy | 4 | 2018 | 8552 | 0.050 |
Why?
|
| Cyclin T | 1 | 2021 | 19 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 580 | 0.050 |
Why?
|
| Leukocyte Count | 2 | 2019 | 1600 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 2159 | 0.050 |
Why?
|
| Virus Diseases | 1 | 2007 | 720 | 0.050 |
Why?
|
| Mexican Americans | 1 | 2002 | 165 | 0.050 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2001 | 99 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 1468 | 0.050 |
Why?
|
| Urination | 2 | 2014 | 202 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2010 | 2566 | 0.050 |
Why?
|
| Quality Control | 2 | 2014 | 828 | 0.050 |
Why?
|
| Exons | 2 | 2007 | 2388 | 0.050 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2013 | 152 | 0.050 |
Why?
|
| Potassium, Dietary | 2 | 1998 | 104 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2015 | 631 | 0.040 |
Why?
|
| Australasia | 1 | 2020 | 21 | 0.040 |
Why?
|
| Paraffin Embedding | 2 | 2012 | 302 | 0.040 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 16939 | 0.040 |
Why?
|
| Proctoscopy | 1 | 2020 | 40 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1941 | 0.040 |
Why?
|
| Americas | 1 | 2020 | 111 | 0.040 |
Why?
|
| Anemia | 1 | 2010 | 1511 | 0.040 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2020 | 136 | 0.040 |
Why?
|
| Hydrogen Sulfide | 1 | 2021 | 141 | 0.040 |
Why?
|
| Recurrence | 2 | 2018 | 8482 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 426 | 0.040 |
Why?
|
| Acetylation | 2 | 2016 | 1062 | 0.040 |
Why?
|
| Fats | 1 | 2020 | 99 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 18137 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2012 | 319 | 0.040 |
Why?
|
| Analysis of Variance | 5 | 2013 | 6238 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2020 | 51 | 0.040 |
Why?
|
| Egypt | 1 | 1999 | 98 | 0.040 |
Why?
|
| Drug Therapy, Combination | 3 | 2016 | 6498 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11481 | 0.040 |
Why?
|
| Administration, Oral | 3 | 2014 | 4035 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2020 | 278 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 165 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 1999 | 97 | 0.040 |
Why?
|
| Neoplasm Seeding | 1 | 2019 | 84 | 0.040 |
Why?
|
| Fecal Incontinence | 1 | 2002 | 241 | 0.040 |
Why?
|
| Androgens | 2 | 2005 | 1291 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 412 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2012 | 4491 | 0.040 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 1999 | 80 | 0.040 |
Why?
|
| Critical Care | 1 | 2012 | 2699 | 0.040 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 766 | 0.040 |
Why?
|
| History, 20th Century | 2 | 2018 | 2773 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2007 | 1902 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2020 | 282 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2015 | 1636 | 0.040 |
Why?
|
| Nutrition Therapy | 1 | 2020 | 102 | 0.040 |
Why?
|
| Muscle Tonus | 1 | 1998 | 82 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 2496 | 0.040 |
Why?
|
| Syndrome | 2 | 2015 | 3280 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 1355 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1630 | 0.040 |
Why?
|
| Survival | 1 | 2019 | 161 | 0.040 |
Why?
|
| Urinary Retention | 1 | 1999 | 106 | 0.040 |
Why?
|
| Saguinus | 1 | 1998 | 13 | 0.040 |
Why?
|
| Nutritive Value | 2 | 2018 | 349 | 0.040 |
Why?
|
| Infant | 5 | 2021 | 36060 | 0.040 |
Why?
|
| Cell Count | 2 | 2015 | 1835 | 0.040 |
Why?
|
| New England | 1 | 2001 | 1050 | 0.040 |
Why?
|
| Rectus Abdominis | 1 | 2019 | 102 | 0.040 |
Why?
|
| DNA Primers | 3 | 2011 | 2819 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 1998 | 107 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 169 | 0.040 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2002 | 357 | 0.040 |
Why?
|
| Norway | 1 | 2019 | 496 | 0.040 |
Why?
|
| Wnt Proteins | 2 | 2013 | 719 | 0.040 |
Why?
|
| Women | 1 | 2020 | 225 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2020 | 281 | 0.040 |
Why?
|
| International Agencies | 1 | 2019 | 244 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2018 | 2913 | 0.040 |
Why?
|
| Abdomen | 1 | 2004 | 1130 | 0.040 |
Why?
|
| Monitoring, Immunologic | 1 | 1998 | 98 | 0.040 |
Why?
|
| Monkey Diseases | 1 | 1998 | 71 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3486 | 0.040 |
Why?
|
| Medical Oncology | 2 | 2020 | 2313 | 0.040 |
Why?
|
| Methylation | 2 | 2007 | 1082 | 0.040 |
Why?
|
| Ketones | 1 | 2019 | 183 | 0.040 |
Why?
|
| Geography | 1 | 2020 | 661 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2414 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 2020 | 319 | 0.040 |
Why?
|
| Financial Management | 1 | 2019 | 161 | 0.040 |
Why?
|
| Metagenome | 1 | 2021 | 450 | 0.040 |
Why?
|
| Metagenomics | 1 | 2021 | 457 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 126 | 0.040 |
Why?
|
| Poultry Products | 1 | 2017 | 10 | 0.040 |
Why?
|
| Tennessee | 1 | 2017 | 119 | 0.040 |
Why?
|
| Pregnancy, High-Risk | 1 | 1997 | 119 | 0.040 |
Why?
|
| Scalp | 1 | 2000 | 389 | 0.040 |
Why?
|
| Fish Products | 1 | 2017 | 29 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 257 | 0.040 |
Why?
|
| Leukemia, Lymphoid | 1 | 2017 | 310 | 0.040 |
Why?
|
| DNA | 3 | 2013 | 7233 | 0.040 |
Why?
|
| Immunoglobulin G | 4 | 2013 | 4541 | 0.030 |
Why?
|
| Maternal Age | 2 | 1997 | 807 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2006 | 1600 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 2471 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1055 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 1266 | 0.030 |
Why?
|
| Forecasting | 1 | 2005 | 2932 | 0.030 |
Why?
|
| Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 174 | 0.030 |
Why?
|
| Genes, myc | 1 | 2017 | 395 | 0.030 |
Why?
|
| Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
| Twins, Dizygotic | 1 | 2017 | 236 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2018 | 175 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2001 | 968 | 0.030 |
Why?
|
| Consumer Product Safety | 1 | 2017 | 123 | 0.030 |
Why?
|
| Marital Status | 1 | 2017 | 433 | 0.030 |
Why?
|
| Pedigree | 1 | 2004 | 4578 | 0.030 |
Why?
|
| Life Change Events | 1 | 2021 | 952 | 0.030 |
Why?
|
| Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2005 | 2086 | 0.030 |
Why?
|
| Flavones | 1 | 2015 | 68 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1998 | 520 | 0.030 |
Why?
|
| Finasteride | 1 | 1996 | 90 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2008 | 3047 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2825 | 0.030 |
Why?
|
| Anthocyanins | 1 | 2015 | 79 | 0.030 |
Why?
|
| Genistein | 1 | 2015 | 86 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 2016 | 155 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5253 | 0.030 |
Why?
|
| Likelihood Functions | 2 | 2014 | 987 | 0.030 |
Why?
|
| Plasma | 1 | 2019 | 584 | 0.030 |
Why?
|
| Homozygote | 3 | 2008 | 1788 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 782 | 0.030 |
Why?
|
| Flavonols | 1 | 2015 | 83 | 0.030 |
Why?
|
| Cytokines | 1 | 2010 | 7343 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2021 | 1167 | 0.030 |
Why?
|
| Individuality | 1 | 2017 | 300 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2017 | 469 | 0.030 |
Why?
|
| Data Collection | 2 | 1997 | 3315 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2015 | 106 | 0.030 |
Why?
|
| Intensive Care Units | 3 | 2014 | 3736 | 0.030 |
Why?
|
| Oral Health | 1 | 2020 | 486 | 0.030 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 1998 | 370 | 0.030 |
Why?
|
| Creatinine | 1 | 2020 | 1903 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2016 | 241 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4107 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 2016 | 297 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 1077 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 1455 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1998 | 924 | 0.030 |
Why?
|
| Sunscreening Agents | 1 | 2015 | 139 | 0.030 |
Why?
|
| Karyotyping | 1 | 2016 | 1171 | 0.030 |
Why?
|
| Internationality | 1 | 2020 | 1004 | 0.030 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
| Serpins | 1 | 2016 | 247 | 0.030 |
Why?
|
| Hysterectomy | 1 | 2020 | 904 | 0.030 |
Why?
|
| Hyperplasia | 2 | 2014 | 1155 | 0.030 |
Why?
|
| Phosphates | 1 | 1998 | 772 | 0.030 |
Why?
|
| Food Preferences | 2 | 1998 | 399 | 0.030 |
Why?
|
| Base Sequence | 3 | 2012 | 12446 | 0.030 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2015 | 326 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 372 | 0.030 |
Why?
|
| Catalase | 1 | 2014 | 216 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 1156 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 362 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 1313 | 0.030 |
Why?
|
| Cataract | 1 | 1999 | 827 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 2016 | 390 | 0.030 |
Why?
|
| Endocrine System | 1 | 2014 | 112 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2009 | 15697 | 0.030 |
Why?
|
| Alcoholism | 1 | 2004 | 1961 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2895 | 0.030 |
Why?
|
| Proinsulin | 1 | 2013 | 135 | 0.030 |
Why?
|
| Cholesterol, Dietary | 2 | 2008 | 223 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2016 | 657 | 0.030 |
Why?
|
| Lost to Follow-Up | 1 | 2013 | 123 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2014 | 266 | 0.030 |
Why?
|
| Fixatives | 1 | 2012 | 91 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 256 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2015 | 474 | 0.030 |
Why?
|
| Health Status | 2 | 2003 | 4081 | 0.030 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2015 | 629 | 0.030 |
Why?
|
| Inpatients | 2 | 2015 | 2581 | 0.030 |
Why?
|
| Leucovorin | 1 | 2014 | 641 | 0.030 |
Why?
|
| Water | 1 | 1999 | 1407 | 0.030 |
Why?
|
| Genetic Linkage | 2 | 2008 | 2381 | 0.030 |
Why?
|
| Observer Variation | 1 | 1999 | 2601 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2013 | 422 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 2315 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2013 | 245 | 0.030 |
Why?
|
| Cecal Neoplasms | 1 | 2012 | 26 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2012 | 103 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 5496 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 1365 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 9585 | 0.030 |
Why?
|
| Serum | 1 | 2013 | 211 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2012 | 153 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 1399 | 0.020 |
Why?
|
| Sigmoid Neoplasms | 1 | 2012 | 54 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 626 | 0.020 |
Why?
|
| Candidiasis, Oral | 1 | 2011 | 57 | 0.020 |
Why?
|
| History, 16th Century | 1 | 2011 | 70 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 223 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1594 | 0.020 |
Why?
|
| Calcium Channels, T-Type | 1 | 2011 | 28 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1871 | 0.020 |
Why?
|
| Phobic Disorders | 1 | 1994 | 437 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2012 | 241 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2013 | 412 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2016 | 12103 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2012 | 507 | 0.020 |
Why?
|
| Laminin | 1 | 2012 | 405 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2012 | 394 | 0.020 |
Why?
|
| Endoscopy | 1 | 2021 | 1838 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 369 | 0.020 |
Why?
|
| Camptothecin | 1 | 2014 | 590 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2012 | 358 | 0.020 |
Why?
|
| Autopsy | 1 | 2015 | 1007 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 858 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26181 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2012 | 406 | 0.020 |
Why?
|
| Serotonin | 1 | 2015 | 1040 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 1135 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1652 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 224 | 0.020 |
Why?
|
| Vitamin E Deficiency | 1 | 2010 | 30 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 173 | 0.020 |
Why?
|
| Sulfites | 1 | 2010 | 83 | 0.020 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2010 | 15 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 1456 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2010 | 49 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 401 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 1166 | 0.020 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 3446 | 0.020 |
Why?
|
| Glycosyltransferases | 1 | 2010 | 118 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2015 | 858 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2017 | 1802 | 0.020 |
Why?
|
| Longevity | 1 | 1997 | 1050 | 0.020 |
Why?
|
| Vitamin A Deficiency | 1 | 2010 | 88 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 1994 | 506 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2011 | 354 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2015 | 897 | 0.020 |
Why?
|
| Surgery Department, Hospital | 1 | 2011 | 177 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 791 | 0.020 |
Why?
|
| Body Fluids | 1 | 2011 | 319 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1741 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2010 | 8313 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2010 | 154 | 0.020 |
Why?
|
| Drug Interactions | 2 | 2004 | 1428 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 686 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 801 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 1722 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2018 | 1940 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2008 | 68 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 732 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 1526 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 503 | 0.020 |
Why?
|
| Interleukin-16 | 1 | 2008 | 34 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 747 | 0.020 |
Why?
|
| Cysteine | 1 | 2013 | 895 | 0.020 |
Why?
|
| Metaplasia | 1 | 2009 | 320 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 698 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 786 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4407 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 247 | 0.020 |
Why?
|
| Betaine-Homocysteine S-Methyltransferase | 1 | 2007 | 6 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 1765 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2873 | 0.020 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2007 | 12 | 0.020 |
Why?
|
| Transcobalamins | 1 | 2007 | 19 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2002 | 3455 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 534 | 0.020 |
Why?
|
| Cattle | 1 | 2013 | 3847 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2004 | 1737 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 869 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2011 | 908 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 1122 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2007 | 284 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2016 | 1266 | 0.020 |
Why?
|
| Developing Countries | 1 | 1999 | 2868 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2018 | 2981 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 867 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 1447 | 0.020 |
Why?
|
| Pancreas, Exocrine | 1 | 2006 | 48 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 491 | 0.020 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2006 | 79 | 0.020 |
Why?
|
| Introns | 1 | 2009 | 978 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 2420 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 2009 | 351 | 0.020 |
Why?
|
| Breast | 1 | 2015 | 1963 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2007 | 356 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 3164 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2145 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1347 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 2442 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2012 | 1724 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2010 | 704 | 0.020 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2010 | 368 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 2007 | 270 | 0.020 |
Why?
|
| MEDLINE | 1 | 2005 | 119 | 0.020 |
Why?
|
| Histones | 1 | 2016 | 2583 | 0.020 |
Why?
|
| World Health Organization | 1 | 2011 | 1312 | 0.020 |
Why?
|
| Heart Diseases | 2 | 2013 | 2809 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1139 | 0.020 |
Why?
|
| Zinc Compounds | 1 | 2005 | 36 | 0.020 |
Why?
|
| Proline | 1 | 2006 | 457 | 0.020 |
Why?
|
| Environment | 1 | 2011 | 1118 | 0.020 |
Why?
|
| Genes, APC | 1 | 2005 | 145 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 1529 | 0.010 |
Why?
|
| Heart Failure | 1 | 2009 | 11847 | 0.010 |
Why?
|
| Ergocalciferols | 1 | 2005 | 110 | 0.010 |
Why?
|
| Drug Utilization | 2 | 2004 | 1195 | 0.010 |
Why?
|
| Multigene Family | 1 | 2007 | 1077 | 0.010 |
Why?
|
| Mammography | 2 | 2006 | 2427 | 0.010 |
Why?
|
| Rural Population | 1 | 2015 | 2268 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2010 | 1521 | 0.010 |
Why?
|
| Viral Load | 1 | 2013 | 3322 | 0.010 |
Why?
|
| Chlamydia Infections | 1 | 2007 | 362 | 0.010 |
Why?
|
| Hemochromatosis | 1 | 2005 | 174 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2005 | 291 | 0.010 |
Why?
|
| Viruses | 1 | 2007 | 376 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2004 | 186 | 0.010 |
Why?
|
| Cadherins | 1 | 2008 | 898 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2009 | 1303 | 0.010 |
Why?
|
| Cluster Analysis | 2 | 2004 | 2698 | 0.010 |
Why?
|
| Isomerism | 1 | 2003 | 197 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 2004 | 288 | 0.010 |
Why?
|
| Mice | 3 | 2016 | 81208 | 0.010 |
Why?
|
| Heterozygote | 1 | 2009 | 2798 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2012 | 2963 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2008 | 3607 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 2448 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2005 | 1175 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1889 | 0.010 |
Why?
|
| Accidental Falls | 1 | 2009 | 1056 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5201 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1894 | 0.010 |
Why?
|
| Pneumonia | 1 | 2013 | 2131 | 0.010 |
Why?
|
| Gestational Age | 1 | 2010 | 3565 | 0.010 |
Why?
|
| Codon | 1 | 2003 | 602 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1697 | 0.010 |
Why?
|
| Genome | 1 | 2009 | 1739 | 0.010 |
Why?
|
| Sample Size | 1 | 2003 | 840 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2015 | 3484 | 0.010 |
Why?
|
| Spinacia oleracea | 1 | 1999 | 12 | 0.010 |
Why?
|
| Intestines | 1 | 2009 | 1907 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2846 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2006 | 1435 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8950 | 0.010 |
Why?
|
| Debrisoquin | 1 | 1998 | 6 | 0.010 |
Why?
|
| Pyridoxine | 1 | 1999 | 108 | 0.010 |
Why?
|
| Temperance | 1 | 1999 | 87 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14372 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2440 | 0.010 |
Why?
|
| Educational Status | 1 | 2006 | 2515 | 0.010 |
Why?
|
| Terminal Repeat Sequences | 1 | 1998 | 70 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2009 | 2907 | 0.010 |
Why?
|
| Leucine | 1 | 1999 | 547 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1998 | 168 | 0.010 |
Why?
|
| Valine | 1 | 1999 | 409 | 0.010 |
Why?
|
| Periodicity | 1 | 1999 | 348 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5325 | 0.010 |
Why?
|
| Cocarcinogenesis | 1 | 1997 | 49 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2010 | 3531 | 0.010 |
Why?
|
| Length of Stay | 1 | 2011 | 6479 | 0.010 |
Why?
|
| Tetrahydrofolates | 1 | 1997 | 58 | 0.010 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 1998 | 247 | 0.010 |
Why?
|
| Swine | 1 | 2006 | 5899 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5791 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1997 | 195 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 22023 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20509 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2010 | 3976 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 2007 | 1607 | 0.010 |
Why?
|
| Homeostasis | 1 | 2006 | 3306 | 0.010 |
Why?
|
| Accidents | 1 | 1996 | 166 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11903 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1997 | 783 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2002 | 12965 | 0.010 |
Why?
|
| Immunoassay | 1 | 1998 | 746 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 17624 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1994 | 151 | 0.010 |
Why?
|
| Canada | 1 | 1999 | 2128 | 0.010 |
Why?
|
| Brachytherapy | 1 | 2001 | 1238 | 0.010 |
Why?
|
| Bone Density | 1 | 2006 | 3534 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 1755 | 0.010 |
Why?
|
| Patient Selection | 1 | 2004 | 4283 | 0.010 |
Why?
|
| Candy | 1 | 1991 | 36 | 0.010 |
Why?
|
| Paternal Age | 1 | 1991 | 87 | 0.010 |
Why?
|
| India | 1 | 1997 | 2336 | 0.010 |
Why?
|
| Cacao | 1 | 1991 | 98 | 0.010 |
Why?
|
| Medical Records | 1 | 1996 | 1407 | 0.010 |
Why?
|
| Postal Service | 1 | 1990 | 95 | 0.010 |
Why?
|
| DNA Replication | 1 | 1997 | 1412 | 0.010 |
Why?
|
| Acute Disease | 1 | 1999 | 7269 | 0.000 |
Why?
|
| Decision Making | 1 | 2002 | 3925 | 0.000 |
Why?
|
| Electrocardiography | 1 | 2001 | 6414 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 2002 | 4446 | 0.000 |
Why?
|
| Random Allocation | 1 | 1990 | 2394 | 0.000 |
Why?
|
| Suicide | 1 | 1996 | 1599 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1990 | 1677 | 0.000 |
Why?
|
| Hypercholesterolemia | 1 | 1991 | 1155 | 0.000 |
Why?
|